Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 2/2011

01-02-2011 | Research Paper

Transcriptional silencing of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon cancer cell line SW620

Authors: Qian Li, Hong Chen

Published in: Clinical & Experimental Metastasis | Issue 2/2011

Login to get access

Abstract

N-Myc downstream-regulated gene 1 (NDRG1) plays vital roles in tumor metastasis suppression and is frequently silenced in metastatic colon cancers. NDRG1 is silenced in a highly metastatic colon cancer cell line SW620. The objective of this study was to investigate the potential mechanisms involved in silencing of the NDRG1 gene. SW480 and SW620 are two colon cancer cell lines established from the same patient with different metastatic potentials, making them an ideal model for investigation of metastatic mechanisms. Knockdown of NDRG1 in SW480 to a level that is similar to that in SW620 also modulated cell cycle and proliferation in SW480 towards the status of the highly metastatic SW620. Epigenetic mechanisms of the transcriptional control of NDRG1 were investigated. The silencing of NDRG1 in SW620 was not due to promoter hyper-methylation as bisulfite sequencing of the NDRG1 promoter showed minimal DNA methylation in both cell lines. On the other hand, chromatin immunoprecipitation showed a significantly higher level of RNA polymerase II (Pol II) association with the NDRG1 promoter in SW480 compared to SW620, in agreement with its gene expression level. The low Pol II binding at the NDRG1 promoter in SW620 was associated with gene-wide decrease in histone H4 acetylation and increase in histone H3 serine 10 phosphorylation. Meanwhile, the NDRG1 coding region showed much higher histone H3 lysine 4 methylation in SW480. In conclusion we observed unique histone modifications in two colon cancer cell lines with different metastatic potentials, indicating possible mechanisms for the down-regulation of NDRG1 in metastatic SW620.
Appendix
Available only for authorised users
Literature
1.
Stafford LJ, Vaidya KS, Welch DR (2008) Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 40(5):874–891CrossRefPubMed
2.
Columbus J, Chiang Y, Shao W et al (2010) Insulin treatment and high fat diet feeding reduces the expression of three TCF genes in rodent pancreas. J Endocrinol 207(1):77–86CrossRefPubMed
3.
Chiang AC, Massagu J (2010) Molecular basis of metastasis. N Engl J Med 359(26):2814–2823CrossRef
4.
Ellen TP, Ke Q, Zhang P et al (2008) NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29(1):2–8CrossRefPubMed
5.
Kurdistani SK, Arizti P, Reimer CL et al (1998) Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 58(19):4439–4444PubMed
6.
Bandyopadhyay S, Pai SK, Hirota S et al (2004) PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res 64(21):7655–7660CrossRefPubMed
7.
Bandyopadhyay S, Wang Y, Zhan R et al (2006) The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res 66(24):11983–11990CrossRefPubMed
8.
Guan RJ, Ford HL, Fu Y et al (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60(3):749–755PubMed
9.
Strzelczyk B, Szulc A, Rzepko R et al (2009) Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Ann Surg Oncol 16(5):1287–1294CrossRefPubMed
10.
Kim KT, Ongusaha PP, Hong YK et al (2004) Function of Drg1/Rit42 in p53-dependent mitotic spindle checkpoint. J Biol Chem 279(37):38597–38602CrossRefPubMed
11.
Stein S, Thomas EK, Herzog B et al (2004) NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279(47):48930–48940CrossRefPubMed
12.
Park H, Adams MA, Lachat P et al (2000) Hypoxia induces the expression of a 43 kDa protein (PROXY-1) in normal and malignant cells. Biochem Biophys Res Commun 276(1):321–328CrossRefPubMed
13.
Salnikow K, Costa M, Figg WD et al (2000) Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res 60(20):5630–5634PubMed
14.
Zhang P, Tchou-Wong KM, Costa M (2007) Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res 67(19):9125–9133CrossRefPubMed
15.
Shimono A, Okuda T, Kondoh H (1999) N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 83(1–2):39–52CrossRefPubMed
16.
Zhang J, Chen S, Zhang W et al (2008) Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region. Gene 417(1–2):5–12CrossRefPubMed
17.
Esteller M (2005) DNA methylation, epigenetics and metastasis. Springer, New YorkCrossRef
18.
Leibovitz A, Stinson JC, McCombs WB III et al (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36(12):4562–4569PubMed
19.
Hewitt RE, McMarlin A, Kleiner D et al (2000) Validation of a model of colon cancer progression. J Pathol 192(4):446–454CrossRefPubMed
20.
Chen H, Pan YX, Dudenhausen EE et al (2004) Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region/leucine zipper transcription factors as well as localized histone acetylation. J Biol Chem 279(49):50829–50839CrossRefPubMed
21.
Jiang K, Shen Z, Ye Y et al (2010) A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1). Scand J Gastroenterol 45(7–8):898–908CrossRefPubMed
22.
Ganepola GA, Mazziotta RM, Weeresinghe D et al (2010) Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors. Clin Exp Metastasis 27(1):1–9CrossRefPubMed
23.
Angst E, Dawson DW, Nguyen A et al (2010) Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells. Pancreas 39(5):675–679CrossRefPubMed
24.
Shahbazian MD, Grunstein M (2007) Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76:75–100CrossRefPubMed
25.
Barski A, Cuddapah S, Cui K et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129(4):823–837CrossRefPubMed
26.
Nowak SJ, Corces VG (2004) Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 20(4):214–220CrossRefPubMed
27.
Johansen KM, Johansen J (2006) Regulation of chromatin structure by histone H3S10 phosphorylation. Chromosome Res 14(4):393–404CrossRefPubMed
Metadata
Title
Transcriptional silencing of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon cancer cell line SW620
Authors
Qian Li
Hong Chen
Publication date
01-02-2011
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 2/2011
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-010-9366-4

Other articles of this Issue 2/2011

Clinical & Experimental Metastasis 2/2011 Go to the issue

Research Paper

A systems view of epithelial–mesenchymal transition signaling states

Abstracts

MRS-AACR Joint Conference on Metastasis 2010

Research Paper

Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides

Research Paper

Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α

Research Paper

Biomarkers of metastatic potential in cultured adenocarcinoma clones
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits